Drug intelligence / Profile preview

clobetasol propionate + miconazole nitrate

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Clobetasol propionate + miconazole nitrate is a combination topical pharmaceutical containing a **potent corticosteroid** (clobetasol propionate) and an **imidazole antifungal** (miconazole nitrate)[1][5][9]. Clobetasol propionate works by binding to glucocorticoid receptors within skin cells, reducing expression of pro-inflammatory mediators and decreasing vasodilation, capillary permeability, and leukocyte migration, leading to relief of inflammation, itching, redness, and swelling[2][5]. Miconazole nitrate acts by disrupting fungal cell membrane synthesis (inhibiting ergosterol formation), causing leakage and death of fungal cells[1][5]. This combination is used primarily in dermatology to treat inflammatory skin conditions where fungal infection is present or suspected, including **eczema**, **dermatitis**, **psoriasis**, and other mixed inflammatory/fungal dermatoses[5][9].

Other names
clobetasol+miconazoleclobetasol propionate+miconazole nitrate
02

Targets

CYP51A1 (Sterol 14α-demethylase)KatGGR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on clobetasol propionate + miconazole nitrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clobetasol propionate + miconazole nitrate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call